老虎證券

美股詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Bone Biologics Corp

2.98
+0.12004.20%
盤後：2.96-0.0200-0.67%17:25 EDT
成交量：7.70萬
成交額：23.18萬
市值：478.38萬
市盈率：-0.14
高：3.09
開：2.91
低：2.91
收：2.86
資料載入中...
總覽公司新聞公告
2021/06/28

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2021/06/07

重要事件披露

8-K - Current report
2021/05/21

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/04/15

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/04/15

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/04/15

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/04/15

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/03/30

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/01/17

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/01/09

重要事件披露

8-K - Current report
2019/11/14

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2019/09/25

重要事件披露

8-K - Current report
2019/08/14

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2019/08/08

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2019/07/17

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2019/06/28

重要事件披露

8-K - Current report
2019/06/21

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2019/05/24

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2019/05/14

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2019/04/16

重要事件披露

8-K - Current report
更多